The changing face of the cost-utility literature, 1990-2012

Value in Health

Volumn 18, Issue 2, 2015, Pages 271-277

  Neumann, Peter J ^a   Thorat, Teja ^a   Shi, Jennifer ^a   Saret, Cayla J ^a   Cohen, Joshua T ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

cost effectiveness analysis; cost utility analysis; quality adjusted life year; review

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISEASE CLASSIFICATION; DISEASES; DRUG INDUSTRY; FUNDING; HUMAN; INCOME; INFECTION; LOWEST INCOME GROUP; MEDICAL DECISION MAKING; MUSCULOSKELETAL DISEASE; NEOPLASM; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; COST BENEFIT ANALYSIS; FACTUAL DATABASE; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; REGISTER; TRENDS;

COST-BENEFIT ANALYSIS; DATABASES, FACTUAL; HUMANS; QUALITY-ADJUSTED LIFE YEARS; REGISTRIES;

EID: 84924962766     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2014.12.002     Document Type: Article

References (18)

1. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York
2. P.J. Neumann, P.W. Stone, and R.H. Chapman The quality of reporting in published cost-utility analyses, 1976-1997 Ann Intern Med 132 2000 964 972
3. P.J. Neumann, D. Greenberg, and N.V. Olchanski Growth and quality of the cost-utility literature, 1976-2001 Value Health 8 2005 3 9
4. T. Thorat, M. Cangelosi, and P.J. Neumann Skills of the trade: the Tufts Cost-Effectiveness Analysis (CEA) Registry J Benefit-Cost Analysis 3 2012 1 9
5. J.E. Siegel, M.C. Weinstein, L.B. Russell, and M.R. Gold Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341
6. J.E. Siegel, G.W. Torrance, and L.B. Russell Guidelines for pharmacoeconomic studies: recommendations from the Panel on Cost-Effectiveness in Health and Medicine. Panel on Cost-Effectiveness in Health and Medicine Pharmacoeconomics 11 1997 159 168
7. M.F. Drummond, and T.O. Jefferson Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party BMJ 313 1996 275 283
8. M.F. Drummond, W.S. Richardson, and B.J. O'Brien Users' guides to the medical literature, XIII: how to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group JAMA 277 1997 1552 1557
9. M.F. Drummond, M.J. Sculpher, and G.W. Torrance Methods for the Economic Evaluation of Health Care Programmes 3rd ed 2014 Oxford University Press Oxford, UK
10. United Nations. Composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. Available from: https://unstats.un.org/unsd/methods/m49/m49regin.htm. [Accessed April 30,2014].
11. The World Bank. The World Bank - countries and economies. Available from: http://data.worldbank.org/country. [Accessed April 30,2014].
12. World Health Organization. Global burden of disease regions used for WHO-CHOICE analyses. Available from: http://www.who.int/choice/demography/regions/en/. [Accessed April 30, 2014].
13. World Health Organization. Health statistics and information systems - global and regional health estimates for 2000-2011. Available from: http://www.who.int/healthinfo/global-burden-disease/estimates-country/en/. [Accessed April 30, 2014].
14. J.F. Bridges, and C. Buttorff What outcomes should US policy makers compare in comparative effectiveness research? Expert Rev Pharmacoecon Outcomes Res 10 2010 217 220
15. M. McGregor, and J.J. Caro QALYs: are they helpful to decision makers? Pharmacoeconomics 24 2006 947 952
16. P.J. Neumann What next for QALYs? JAMA 305 2011 1806 1807
17. German Institute for Quality and Efficiency in Health Care. General methods for the assessment of the relation of benefits to cost. Available from: https://www.iqwig.de/download/General-Methods-for-the-Assessment-of-the-Relation-of-Benefits-to-Costs.pdf. [Accessed June 16, 2014].
18. P.J. Neumann, and M.C. Weinstein Legislating against use of cost-effectiveness information N Engl J Med 363 2010 1495 1497